Skip to main content
. 2020 Oct 12;15(5):599–611. doi: 10.1007/s11523-020-00748-4

Fig. 1.

Fig. 1

Study design in patients with NHL grade 1–3a follicular lymphoma stage II–IV CD20 +. IV intravenous, NHL non-Hodgkin lymphoma, RP reference product.  indicates IV infusion. *Post-treatment tumor assessments